MCD
52
2
DNB
82
4
NDAQ
62
2
CTSH
56
2
URI
65
5
RSG
71
3
PRGO
39
3
CF
57
-2
ORCL
65
-2
VNO
60
10
AVY
53
3
SE
61
-4
PVH
62
5
FDX
43
3
MET
72
5
ILMN
42
5
UPS
60
9
MTB
67
2
INTU
56
-4
NKE
36
6
MCD
52
2
DNB
82
4
NDAQ
62
2
CTSH
56
2
URI
65
5
RSG
71
3
PRGO
39
3
CF
57
-2
ORCL
65
-2
VNO
60
10
AVY
53
3
SE
61
-4
PVH
62
5
FDX
43
3
MET
72
5
ILMN
42
5
UPS
60
9
MTB
67
2
INTU
56
-4
NKE
36
6
Financhill
Back

AIM ImmunoTech Vs. Perspective Therapeutics Industry Stock Comparison

Sell
30

AIM
AIM ImmunoTech

Last Price:
0.21
Seasonality Move:
1.22%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
30
AIM ImmunoTech (AIM) is a Sell

Is AIM ImmunoTech a Buy, Sell or Hold?

  • The current AIM ImmunoTech [AIM] share price is $0.21. The Score for AIM is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • AIM is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AIM Stock Price Chart

What is AIM ImmunoTech's stock price today?

  • The AIM ImmunoTech share price today is $0.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AIM is experiencing selling pressure, which indicates risk of future bearish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

AIM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 39.42 Sell
Chaikin Money Flow: -65575 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.22 - 0.26) Sell
Bollinger Bands (100): (0.25 - 0.35) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

AIM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.22 Sell
20-day SMA: 0.24 Sell
50-day SMA: 0.26 Sell
200-day SMA: 0.36 Sell
8-day EMA: 0.22 Sell
20-day EMA: 0.23 Sell
50-day EMA: 0.26 Sell
200-day EMA: 0.35 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

AIM ImmunoTech Earnings Growth & AIM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.00 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

AIM ImmunoTech Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):